A different chemo plan helped one patient with choriocarcinoma in the brain
Original title: High-Dose Busulfan and Thiotepa Followed by Autologous Stem Cell Transplantation for Refractory Choriocarcinoma with Central Nervous System Metastases: A Case Report.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was tried in one patient and written up as a case, not tested in a trial.
The short version
Doctors tried chemo drugs that reach the brain, and one patient's cancer stopped growing.
What was studied. This is a report about one patient. The patient had choriocarcinoma that spread to the brain. It had stopped responding to the drugs carboplatin and etoposide. Doctors then gave high doses of two other drugs, busulfan and thiotepa.
What they found. The cancer did not grow after the new drug plan. The patient also got back a very good quality of life. Doctors chose these two drugs because they can pass into the brain. The usual drugs do not get into the brain well.
What this means, and what it doesn't
What it could mean: For a few patients, this may be another option to discuss with a doctor. It could matter most when radiation is no longer safe and surgery is not possible. You would need a cancer team that gives this kind of high dose chemo.
What it doesn't mean: This is not proof that the plan works. It is a report about one single patient, not a trial. We do not know if it helps others, or how long the benefit lasts. It is not a cure, and it is not standard care today. Much more research is needed first.
Source: PubMed, September 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.